智通财经APP获悉，神威药业(02877)午后跌超7%，截至发稿，跌7.63%，报8.11港元，成交额1559.62万港元。
消息面上，神威药业发布2024年年度业绩，营业额37.78亿元(人民币，下同)，同比减少16.35%；年内溢利8.4亿元，同比减少13.35%；每股基本盈利111分；拟派发第一次中期股息每股36分。
公告称，2024年集团整体营业额明显减少，主要是由于呼吸类、感冒类、抗感染类等药品受到上一年度需求爆发增长带来的高基数影响，同时加上因宏观经济导致市场需求变化以及政策调整等多重因素，导致整体销售额显著下降，其中注射液产品销售额取得较大跌幅，注射液产品销售额于年内共减少29%，其中清开灵注射液销售额录得40.8%负增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.